Traders should monitor voting outcomes and potential regulatory approvals, as failure to secure stockholder approval could derail the deal. The lack of disclosed financial terms in this communication suggests referencing the S-4 proxy statement for deal specifics.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 20 $329.71entry
- T+1 · 7mo ago −0.82%α −0.17% · $327.00
- T+5 · 7mo ago −0.52%α −1.44% · $327.98
- T+20 · 6mo ago −0.96%α −5.16% · $326.54
- T+60 · 4mo ago −3.94%α −10.71% · $316.73
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Penumbra Inc sent a letter to its stockholders urging them to vote in favor of the proposed acquisition by Boston Scientific Corporation, with the special meeting scheduled for May 6, 2026. The board unanimously recommends approval.
Key Financial Metrics
Key Facts
- Penumbra's board unanimously recommends stockholders vote FOR the merger with Boston Scientific.
- Special meeting to vote on the merger is scheduled for May 6, 2026.
- Failing to vote has the same effect as voting against the merger.
- The proxy statement/prospectus was declared effective on April 1, 2026.
- This filing is a Rule 425 communication, part of the merger solicitation process.
Financial Impact
Potential acquisition of Penumbra Inc by Boston Scientific, though specific deal value and terms are not disclosed in this filing.
Risk Factors
- Risk that the merger fails to obtain required stockholder approval.
- Potential for regulatory delays or opposition to the acquisition.
- Market uncertainty until the special meeting vote on May 6, 2026.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0000950103-26-005882 |
| Document: 0000950103-26-005882-index-headers.html | 0000950103-26-005882 |
| Document: 0000950103-26-005882-index.html | 0000950103-26-005882 |
| Document: 0000950103-26-005882.txt | 0000950103-26-005882 |
Track record
11 reports on PEN
1 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +1.63% at T+20 after the May 6, 2026 report. 1 of 4 went positive at some point.
Filters
- Nov 9, 20267d ago Institutional Cluster Mixed 3/10 Entry $321.46 Now $320.62 −0.26% settles Feb 8
- Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $319.21 Now $320.62 +0.44% settles Feb 4
- Oct 29, 202618d ago 8-K Neutral 5/10 No price data
- Oct 29, 202618d ago Press Release Neutral 5/10 Entry $318.95 Now $320.62 +0.52% settles Jan 28
- Jul 30, 202615w ago Press Release Bearish 6/10 Entry $321.19 to $325.22 Now $320.62 +0.18% ▼ −1.25% +1.20% vs SPY
- May 7, 202627w ago 425 Bullish 7/10 Entry $324.65 to $323.02 Now $320.62 −1.24% ▼ −0.50% −4.34% vs SPY
- May 6, 202627w ago 8-K Bearish 6/10 Entry $324.65 to $323.02 Now $320.62 +1.24% ▲ +0.50% +4.34% vs SPY
- Apr 29, 202628w ago DEFA14A Neutral 2/10 Entry $326.48 to $319.49 Now $320.62 −1.79% ▼ −2.14% −5.25% vs SPY
- Apr 17, 202630w ago 425 Neutral 4/10 Viewing Entry $329.71 to $316.73 Now $320.62 −2.76% ▼ −3.94% −10.71% vs SPY
- Apr 1, 202632w ago DEFM14A Bullish 8/10 Entry $330.36 to $315.75 Now $320.62 −2.95% ▼ −4.42% −18.58% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers